Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dss Inc DSS

DSS, Inc. is a multinational, public company. It operates its business through six divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, Alternative Trading, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons... see more

Recent & Breaking News (NYSEAM:DSS)

DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

GlobeNewswire May 16, 2023

DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders

GlobeNewswire May 1, 2023

DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders

GlobeNewswire April 19, 2023

DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM

GlobeNewswire April 17, 2023

Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?

TheNewsWire March 27, 2023

DSS Inc (NYSE American: DSS) Has Three IPO Spinoffs Planned For 2023 — Is It On Your Watchlist?

TheNewsWire March 13, 2023

This ‘Mini-Berkshire Hathaway’ Style Company’s Strategy Of Building And Spinning Off Companies Is Giving Retail Investors Pure-Play Opportunities For Additional Stock

TheNewsWire March 7, 2023

DSS Announces Letter to Shareholders   

GlobeNewswire March 2, 2023

Impact BioMedical Scientific Partner GRDG Sciences to be Featured in New Documentary

GlobeNewswire October 19, 2022

DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

GlobeNewswire August 30, 2022

Impact BioMedical Develops Quantum Antihistamine

GlobeNewswire July 26, 2022

DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs

GlobeNewswire July 21, 2022

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

GlobeNewswire July 13, 2022

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

GlobeNewswire June 28, 2022

DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

GlobeNewswire June 7, 2022

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

GlobeNewswire May 6, 2022

Impact BioMedical's Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization's ISA Division

GlobeNewswire March 3, 2022

CORRECTION - DSS Announces Letter to Shareholders

GlobeNewswire February 28, 2022

DSS Announces Letter to Shareholders

GlobeNewswire February 28, 2022

DSS to Present at Aegis Virtual Conference

GlobeNewswire February 22, 2022